Breath test for cancer in the works
Links shared publicly online about this topic.
- 1,784total visits
Breath test for cancer in the works
View full resource at nydailynews.com
Tags: Cancer, Lung Cancer, Lung, Breathing, Scientist
Most Recently Shared on August 31, 2009 at 9:05 am By:
Breath test for cancer in the works: Screening for lung cancer could soon be as easy as a simple breath test. Sc.. http://bit.ly/2wvvh2
Everything I Didn't Learn From Taking A Personal Genome Test | The Awl
theawl.com — “It took us ten years and $3 billion to map the human genome, and when the first working draft appeared in 2000, it came with lots of predictions: We were going to crack the genetic code for disease, predict heart attacks and cure cancer. Twelve years later, that isn't how it worked out. Instead of dramatic scientific breakthroughs, the most successful outgrowth has been a crop of VC-fueled personal genetics companies. The concept is simple: for a fee, they’ll tell you everything science kno” View full resource at theawl.com
Most Recently Shared on May 1, 2012 at 7:28 pm By:
Stephen Meyers, MD Doctor, Family Medicine Doctor, and Physician
See if you think it was worth it: Everything I Didn't Learn From Taking A Personal Genome Test http://t.co/hmeokBiT @awl via @scotthensley
Many older men still get prostate cancer testing - Yahoo! News
news.yahoo.com — “From Yahoo! News: NEW YORK (Reuters Health) - Despite recommendations not to screen men age 75 and older for prostate cancer, most elderly men still get tested, according to a new survey. "I think there is a lot of push from patients to get (the test)," said Dr. Edward Messing from the University of Rochester Medical Center, who worked on the study. "Eighty-year-olds don't think they're that old anymore, and maybe they're not. They think they still have a life ahead of them."” View full resource at news.yahoo.com
Most Recently Shared on April 26, 2012 at 8:41 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Many older men still get prostate cancer testing: NEW YORK (Reuters Health) - Despite recommendations not to scr... http://t.co/TzfoC2dt
St. Jude Children's Research Hospital
stjude.org — “St. Jude Children?s Research Hospital, located in Memphis, Tennessee, is internationally recognized for its pioneering work in finding cures and saving children with pediatric cancer and other catastrophic diseases. The diverse research at St. Jude ranges from discovery-focused and hypothesis-testing laboratory studies to clinical trials of specific agents, regimens, or therapeutic interventions. St. Jude freely shares its discoveries with scientific and medical communities around the world. Eac” View full resource at stjude.org
Most Recently Shared on March 29, 2012 at 9:18 pm By:
St. Jude Hospital and Children's Hospital
Did you already visit the 50th anniversary Spanish @Stjude Website? Be part of our history. Visit http://t.co/Wc4HzJGe
St. Jude Children's Research Hospital
stjude.org — “St. Jude Children?s Research Hospital, located in Memphis, Tennessee, is internationally recognized for its pioneering work in finding cures and saving children with pediatric cancer and other catastrophic diseases. The diverse research at St. Jude ranges from discovery-focused and hypothesis-testing laboratory studies to clinical trials of specific agents, regimens, or therapeutic interventions. St. Jude freely shares its discoveries with scientific and medical communities around the world. Eac” View full resource at stjude.org
Most Recently Shared on March 29, 2012 at 9:18 pm By:
St. Jude Hospital and Children's Hospital
¿Ya visitaste la nueva página del cincuenta aniversario de @StJude? Se parte de la historia en http://t.co/m79mF8U9
Scientists reprogram cancer cells with low doses of epigenetic drugs
labspaces.net — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at labspaces.net
Most Recently Shared on March 23, 2012 at 9:00 pm By:
Scientists reprogram cancer cells with low doses of epigenetic drugs - http://t.co/ClPQn0Bb
Scientists reprogram cancer cells with low doses of epigenetic drugs
sciencedaily.com — “Experimenting with cells in culture, researchers have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at sciencedaily.com
Most Recently Shared on March 23, 2012 at 7:45 am By:
Scientists reprogram cancer cells with low doses of epigenetic drugs http://t.co/bVOuJWu6
Scientists reprogram cancer cells with low doses of epigenetic drugs
sciencedaily.com — “Experimenting with cells in culture, researchers have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at sciencedaily.com
Most Recently Shared on March 23, 2012 at 5:35 am By:
Scientists reprogram cancer cells with low doses of epigenetic drugs http://t.co/8BE8AjH6
Scientists reprogram cancer cells with low doses of epigenetic drugs
sciencedaily.com — “Experimenting with cells in culture, researchers have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at sciencedaily.com
Most Recently Shared on March 23, 2012 at 5:24 am By:
Scientists reprogram cancer cells with low doses of epigenetic drugs: Experimenting with cells in culture, resea... http://t.co/oSdZUhBO
Scientists Reprogram Cancer Cells with Low Doses of Epigenetic Drugs
newswise.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 9:42 pm By:
newswise Health Communicator and Health News
Scientists Reprogram Cancer Cells with Low Doses of Epigenetic Drugs http://t.co/MOQlJ8Gs
Scientists Reprogram Cancer Cells with Low Doses of Epigenetic Drugs
newswise.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 9:07 pm By:
Scientists Reprogram Cancer Cells with Low Doses of Epigenetic Drugs: Experimenting with cells in cultur... http://t.co/ZG6CRT0I #cancer
Scientists reprogram cancer cells with low doses of epigenetic drugs
medicalxpress.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing ...” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 9:05 pm By:
PhysOrg Health News Health News
Scientists reprogram cancer cells with low doses of epigenetic drugs http://t.co/yarKOjgm
New Method To Test A Tumor's Resistance To An Experimental Therapy
medicalnewstoday.com — “Drug resistance is a serious problem for cancer patients - over time, a therapy that was once providing some benefit simply stops working. Scientists at Sanford-Burnham Medical Research Institute” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 7:05 am By:
New Method To Test A Tumor's Resistance To An Experimental Therapy http://t.co/6HzHHWnq #cancer
PSA Testing Reduces Prostate Cancer Mortality, Follow-Up Study Shows - Physician's First Watch
firstwatch.jwatch.org — “Screening with prostate-specific antigen (PSA) testing reduces prostate cancer deaths, according to a follow-up report from the European Randomized Study of Screening for Prostate Cancer published in the New England Journal of Medicine. (The . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 17, 2012 at 7:43 am By:
St. Jude Children's Research Hospital
stjude.org — “St. Jude Children?s Research Hospital, located in Memphis, Tennessee, is internationally recognized for its pioneering work in finding cures and saving children with pediatric cancer and other catastrophic diseases. The diverse research at St. Jude ranges from discovery-focused and hypothesis-testing laboratory studies to clinical trials of specific agents, regimens, or therapeutic interventions. St. Jude freely shares its discoveries with scientific and medical communities around the world. Eac” View full resource at stjude.org
Most Recently Shared on March 16, 2012 at 5:11 pm By:
St. Jude Hospital and Children's Hospital
¿Sabías que @StJude fue fundado por un hijo de inmigrantes? Conoce la historia de Danny Thomas en http://t.co/EOJonRnD
Mastectomy without cancer: some women choose not to live with hereditary breast-cancer risk - thestar.com
thestar.com — “Removing breasts to prevent cancer may grow more common as a result of genetic testing, breast reconstruction techniques” View full resource at thestar.com
Most Recently Shared on March 12, 2012 at 2:00 pm By:
Women'sHealthMatters Health Site
The work of Steven Narod and Mitchell Brown are featured in a @TorontoStar article on hereditary #BreastCancer: http://t.co/LX9N0M77
Advertisement
